Stocks and Investing Stocks and Investing
Mon, May 16, 2022

Joseph Pantginis Maintained (TPST) at Strong Buy with Decreased Target to $35 on, May 16th, 2022


Published on 2024-10-27 21:05:30 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "Tempest Therapeutics, Inc." (TPST) at Strong Buy with Decreased Target from $51 to $35 on, May 16th, 2022.

Joseph, nor any peers, have made any analyst calls on TPST in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources